Noteworthy - December 2020

December 16, 2020 Providence inScope Content Team

Providence cancer researchers win international awards

Providence Cancer Institute researchers attended (virtually) the 35^th annual meeting of the Society for Immunotherapy of Cancer, where scientists from around the world convened. In addition to contributing to 15 conference posters, the Providence team received several notable awards:

Inaugural Steven A. Rosenberg, M.D., Ph.D., Scholar Award: Eric Tran, Ph.D.
Award for Extraordinary Service to the Society: Bernie Fox, Ph.D.
SITC Team Science Award: Earle A. Chiles Research Institute
Panelist for radiation and immunotherapy session: Kristina Young, M.D., Ph.D.

Chief diversity and inclusion officer named

Providence in Oregon has named Stephanie Piimauna as its new chief diversity and inclusion officer. Stephanie brings more than 25 years of diversity, equity and inclusion experience leading corporate strategy, business development, change management and talent development. She has led DEI strategies and programs in industries including hospitality, aerospace, transportation, law, retail and telecommunications. Her most recent role was with Gilead Sciences in Las Vegas.

Virtual pediatric grand rounds

Providence Children’s Health invites providers to participate in virtual pediatric grand rounds. A minimum of 10 events (45 minutes each) is offered annually on pediatric topics designed to support your practice. It is free to participate without CME. An innovative and affordable CME subscription model is available at the provider and practice level.

Pediatric topics vary and may focus on areas such as: surgery, ENT, gastroenterology, endocrinology, neurology, orthopedics, emergency medicine and more. See flyer for more information, to share with colleagues or to register.

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Noteworthy - December 2020

About the Author

Previous Article

Next Article

Noteworthy - December 2020

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).